Related Experiment Video
Updated: May 24, 2026
10:17
The Tail Suspension Test
Published on: January 28, 2012
Lithium and kidney, 60 years later.
1Centro Studi e Ricerche “Gaetano Perusini”, Rome, Italy. michele.raja@libero.it
Current Drug Safety
|March 20, 2012
Summary
Lithium remains a vital psychiatric treatment, but its use is limited by side effects and monitoring needs. This review focuses on managing lithium-induced renal side effects to improve patient outcomes.
Area of Science:
- Psychiatry
- Nephrology
Background:
- Lithium is a cornerstone psychiatric medication for various mood disorders and behavioral issues.
- Despite its efficacy, lithium's narrow therapeutic index and significant side effect profile limit its use.
- Frequent monitoring requirements further contribute to underutilization of this valuable drug.
Purpose of the Study:
- To review the renal safety profile of lithium therapy.
- To outline strategies for managing lithium-associated renal side effects.
Main Methods:
- Literature review of studies on lithium's renal effects.
- Analysis of clinical management strategies for lithium-induced nephrotoxicity.
Main Results:
- Renal side effects are common during lithium treatment, ranging from mild to severe.
- Severe cases can lead to chronic renal failure and end-stage renal disease.
- Proactive management and awareness of side effects are crucial.
Conclusions:
- Effective management of renal side effects is essential to overcome barriers to lithium use.
- Clinicians must be knowledgeable about minimizing lithium-associated renal complications.
- Optimizing lithium therapy can improve outcomes for patients with mood disorders.
Related Concept Videos
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:29Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...